Some Side Effects of Androgen Deprivation Therapy (ADT) Induced by Estrogen Deficiency
Androgen deprivation therapy (ADT) is an old standby for the treatment of men with metastatic or advanced prostate cancer. We have long known that testosterone plays an integral role in the progression of prostate cancer, [...]
Some Good News In England & Wales for Men with Advanced Prostate Cancer
The National Health Service cost regulators for England and Wales have recommended the use of Zytiga in the treatment of men with castrate resistant advanced prostate cancer. The National Institute for Health and Clinical Excellence [...]
Important Survey for you
Here's a great opportunity to participate in an advanced prostate cancer marketing survey, earn $40 dollars for yourself and help move our understanding of our disease just a little bit further forward. *What is the [...]
Failing Zytiga – Some Requirements to Access the MDV-3100 Early Access Trial
Many of us in the United States with advanced prostate cancer who have failed Zytiga are looking to enter the Early Access MDV-3100 Clinical Trial. However, you need to be aware that there are some [...]
Some Great News for our Fellow European Survivors
Recently, it was announced that there was a submission by Astellas and Medivation to the European Regulatory Agency for Enzalutamide (MDV-3100) for the treatment of men with advanced prostate cancer post-chemotherapy The basis of the [...]
FDA Approves the PHI Test to Screen for Prostate Cancer
Not in the normal realm of advanced prostate cancer, but important for the prostate cancer world is the news that the FDA has approved a new screening test for prostate cancer. The currently used screening [...]